Therefore, we applied a new quantitative sojourn time-based method to ascertain the number of missing asymptomatic cancer cases that arise in subjects with a negative PSA result after screening to correct the sensitivity and specificity of this test and the resulting ROC curve. The gene discussed is KLK3; the disease is cancer.